Recombinant human activated protein C, package labeling, and hemorrhage risks.
Sweeney
Daniel A
DA
Natanson
Charles
C
Eichacker
Peter Q
PQ
D000890:Anti-Infective Agents / Q000009:adverse effects*; D004348:Drug Labeling; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D011486:Protein C / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D012307:Risk Factors
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated